NetworkNewsBreaks

FridayMar 17, 2017 10:52 am

NetworkNewsBreaks – Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) Enters Agreement to Merge with Molecular Templates; Shares Soar

Threshold Pharmaceuticals (NASDAQ: THLD) shares soared 41% following early morning news that the company has entered into a definitive agreement to merge with Molecular Templates, Inc., a privately held biopharmaceutical company. Per the agreement, Molecular Templates will merge with a wholly-owned subsidiary of Threshold in an all-stock transaction, resulting in a combined Nasdaq-listed company focused on the development of novel treatments for cancer. At the close of the transaction, Longitude Capital will invest $20 million, subject to certain conditions, including the receipt of additional equity financing commitments of $20 million. Molecular Templates’ proprietary technology has been used to create biologic…

Continue Reading

ThursdayMar 16, 2017 12:35 pm

NetworkNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) CEO Featured in Benzinga Article

India Globalization Capital (NYSE: IGC) was recently featured in an article detailing the company's strategic move to the cannabis industry and future plans for the company. In the past, IGC was a company primarily focused on the beneficiation of iron ore. That focus changed a few years ago when iron ore prices plummeted, often selling below its cost of production. For the last three years, the company has shifted its focus to tackling the cannabis industry, or more specifically, medical cannabis use. The company is currently developing a portfolio to address epilepsy, cachexia, PTSD, Alzheimer’s, and Parkinson’s. “We came up…

Continue Reading

ThursdayMar 16, 2017 12:32 pm

NetworkNewsBreaks – Heat Biologics (NASDAQ: HTBX) Receives Grant to Develop Zika Vaccine

Heat Biologics, Inc. (NASDAQ: HTBX) this morning said Natasa Strbo, M.D., D.Sc., research assistant professor of Microbiology and Immunology at the University of Miami Miller School of Medicine, has received a three-year $981,901 grant from the Florida Department of Health 2016-17 Zika Research Grant Initiative to further develop and test the gp96-based Zika vaccine. The vaccine is being developed under a collaboration between the University of Miami and Heat’s wholly owned subsidiary, Zolovax, Inc., which has licensed the patent. The grant is expected to cover the preclinical development of the Zika vaccine, and allow Dr. Strbo to expand her laboratory…

Continue Reading

ThursdayMar 16, 2017 12:24 pm

NetworkNewsBreaks – Avid’s (NASDAQ: AVID) Avid NEXIS™ Selected by Middlesex University; Shares Sink

Avid® (NASDAQ: AVID) shares are down 18% in mid-day trade. The company this morning said that the Faculty of Arts and Creative Industries at Middlesex University in London has invested in Avid NEXIS™. Powered by the MediaCentral® Platform, Avid NEXIS provides the reliability, performance and scalability that the faculty needs to support the expanding department and prepare graduates for success in the media industries. The university faculty and stake holders have invested in Avid NEXIS | E4 and Avid NEXIS | E2 systems with the addition of a System Director Appliance for the flexibility to support the increasing needs of…

Continue Reading

ThursdayMar 16, 2017 10:40 am

NetworkNewsBreaks – Player’s Network, Inc. (PNTV) Announces Engagement of NetworkNewsWire

Diversified holding company Player's Network, Inc. (OTCQB: PNTV) this morning announced its engagement of NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company that delivers a new generation of social communication solutions, news aggregation and syndication, and enhanced news release services. Leveraging an investor-based distribution network that includes more than 5,000 key syndication outlets, various newsletters, numerous social media channels, blogs, and other outreach tools, NNW will look to generate greater brand awareness for Player’s Network as the company seeks to expand its presence in both the media and cannabis industries. “This partnership is an extension of our new shareholder…

Continue Reading

ThursdayMar 16, 2017 10:25 am

NetworkNewsBreaks – BlackStar Enterprise Group, Inc. (BEGI) CFO Featured in Exclusive Audio Interview with NetworkNewsWire

Merchant banking and finance company BlackStar Enterprise Group, Inc. (OTC: BEGI) was recently featured in an exclusive audio interview with NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company that delivers a new generation of social communication solutions, news aggregation and syndication, and enhanced news release services. The full interview can be heard at http://nnw.fm/begi-interview-march-2017. In the interview, CFO Joseph E. Kurczodyna introduces prospective investors to BlackStar’s operations by describing some of the fundraising challenges that face many private companies. “Right now you've got CEOs raising money, you've got companies that are crowdfunding, and there's a big gap,” he stated.…

Continue Reading

ThursdayMar 16, 2017 9:54 am

NetworkNewsBreaks – eXp World Holdings, Inc. (EXPI) Reaches 3,000 Agents through eXp Realty LLC

eXp World Holdings, Inc. (OTCQB: EXPI), holding company for the Agent-Owned Cloud Brokerage®, this morning announced that eXp Realty’s family of agents and brokers now includes more than 3,000 members across its operating markets in the United States and Canada. This figure represents a 25 percent increase from the company’s total of 2,401 agents at the end of 2016, as well as an increase of more than 200 percent year-over-year. “eXp Realty continues to attract an increasing number of top agents, teams and brokers, which has catapulted us to a place alongside the top residential brokerage firms in the country,”…

Continue Reading

ThursdayMar 16, 2017 9:30 am

NetworkNewsBreaks – Social Reality, Inc. (NASDAQ: SRAX) to Host 2016 Financial Results Conference Call on March 30

Internet advertising company Social Reality, Inc. (NASDAQ: SRAX) this morning announced plans to host a conference call discussing its fourth quarter 2016 financial results at 1:30 pm PT on March 30, 2017. In addition to giving prospective investors a financial and operational summary of SRAX’s progress during 2016, CEO Christopher Miglino and CFO J.P. Hannan are expected to offer insight into the company’s vision for the coming months during the call. To access the conference call, investors should dial (877) 681-3372 if calling from the United States or Canada, or (719) 325-4907 if calling internationally. The passcode for both numbers…

Continue Reading

WednesdayMar 15, 2017 4:24 pm

NetworkNewsBreaks – Health Care IT & Big Data Analytics Expanding with the Rise of Value-Based Care Model

At more than $3 trillion per year, U.S. health care spending is a hefty financial burden, demonstrating the need for a more cost- and resource-effective solution. Designed to replace the traditional fee-for-service approach that compensates care providers for the number of services they deliver, the value-based model is emerging as a preferred model that pays providers according to the results of their care. As the health care system shifts toward this approach, there is a growing need for efficient technology platforms and big data analytics that can help curtail rising medical costs and make the overall system more efficient. Leading…

Continue Reading

WednesdayMar 15, 2017 4:23 pm

NetworkNewsBreaks – Biotech Innovations Drive Cannabinoid-Based Pharmaceutical Market Growth

As the medical marijuana market continues to grow, so does the number of biotech companies expanding their research into the development of innovative cannabinoid-based pharmaceuticals and delivery systems. It is estimated that the U.S. consumer market for cannabinoid pharmaceuticals will increase exponentially in upcoming years, exceeding $50 billion by 2029, according to Statista. This doesn’t appear to be a lofty forecast, given the prominence this market segment has gained by the sustained efforts and innovations of leading biotech companies such as InMed Pharmaceuticals, Inc. (IMLFF) (InMed Profile), GW Pharmaceuticals plc (GWPH), Zynerba Pharmaceuticals, Inc. (ZYNE), AXIM® Biotechnologies, Inc. (AXIM) and…

Continue Reading